Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 32Breast Neoplasms 21Neoplasms 17Prostatic Neoplasms 11Obesity 8Sarcopenia 6Colorectal Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Head and Neck Neoplasms 5Polycystic Ovary Syndrome 4Signs and Symptoms 3Multiple Myeloma 3Lymphedema 3Inflammation 3Fatigue 3Diabetes Mellitus, Type 2 3Colonic Neoplasms 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Pharyngeal Neoplasms 2Overweight 2Osteoporosis, Postmenopausal 2Osteoporosis 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Insulin Resistance 2Hematopoietic and Lymphatic System Neoplasm 2

Interventions

Gemcitabine 113Cisplatin 77Oxaliplatin 46pembrolizumab 35Fluorouracil 33Capecitabine 31durvalumab 27Leucovorin 27lenvatinib 26Magnetic Resonance Spectroscopy 15Irinotecan 14Drug Therapy 13Biopsy 13Nivolumab 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11130-nm albumin-bound paclitaxel 11pemigatinib 10apatinib 10Taxes 10Radiotherapy 10Floxuridine 10Folfox protocol 9Bevacizumab 9S 1 (combination) 8Platinum 8Photochemotherapy 8Liver Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Resistance Training × Clear all
NCT05921552 2025-12-04

Senior Adult Hepatobiliary Prehab Study

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Active not recruiting
25 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡